Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 413
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02574897 | The Ability of Electronic Patient Symptom Reporting to Reduce Symptom Burden During Hospitalization for Chemotherapy | ||
| NCT00380029 | Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer | ||
| NCT01688323 | Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer | ||
| NCT02682199 | Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation | ||
| NCT05542407 | ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer | ||
| NCT04274465 | Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia | ||
| NCT05823740 | Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers | ||
| NCT00448201 | Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease | ||
| NCT07296861 | HomeGrown: A Family-based Lifestyle Intervention to Support Healthy Development of Young Children With Down Syndrome | ||
| NCT02768792 | High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML | ||
| NCT07484139 | H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC) | ||
| NCT03446157 | Palbociclib and Cetuximab in Metastatic Colorectal Cancer | ||
| NCT03569761 | A Culturally-adapted Colorectal Cancer Screening Decision Aid Designed for American Indians | ||
| NCT00483405 | Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer | ||
| NCT03820024 | MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback | ||
| NCT05937659 | Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RT | ||
| NCT04176497 | PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study | ||
| NCT04280640 | Relationship Between Circulating Tumor Cell Cultures' Treatment Response and Clinical Outcomes | ||
| NCT05483023 | 18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy | ||
| NCT03978624 | Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer | ||
| NCT03077243 | P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC | ||
| NCT05714982 | Impact of E-cigarette Device Warnings | ||
| NCT03174275 | Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma | ||
| NCT04670068 | Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian | ||
| NCT04342260 | Improving Quality of Life After Thoracic Surgery Using Patient-Reported Outcomes | ||
| NCT07214610 | Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study | ||
| NCT05414097 | Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa | ||
| NCT00379509 | Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer | ||
| NCT04092816 | Fathers and Mothers Invested in Lives of Their Youth (FAMILY) Study: A Pilot Intervention | ||
| NCT00489216 | Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids | ||
| NCT03769415 | Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA | ||
| NCT00334438 | Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma | ||
| NCT02045186 | Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC) | ||
| NCT02139774 | Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer | ||
| NCT04990934 | Transitioning Care: Perspectives of Older Women With Early Breast Cancer on Current Telemedicine Modalities | ||
| NCT00225420 | Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer | ||
| NCT04836455 | Impact of Vaping Prevention Advertisements | ||
| NCT01263418 | Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas | ||
| NCT05985538 | Impact of E-Cigarette Prevention Messages on Adolescents | ||
| NCT05620329 | UNC Pleural Fluid Registry | ||
| NCT04931251 | Addressing Cancer-Related Financial Toxicity in Rural Oncology Care Settings | ||
| NCT05630131 | ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy | ||
| NCT01612351 | Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery | ||
| NCT03418792 | Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx | ||
| NCT02010567 | Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer | ||
| NCT05592665 | PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology | ||
| NCT01655745 | Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer | ||
| NCT01137643 | Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer | ||
| NCT05574478 | Metastatic Breast Cancer-Specific Prognostic Tool | ||
| NCT03339206 | Enhancing Source Credibility in Tobacco Regulatory Communications |
